Literature DB >> 15039354

Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.

Rosanna Mundy1, Liljana Petrovska, Katherine Smollett, Nandi Simpson, Rebecca K Wilson, Jun Yu, Xuanlin Tu, Ilan Rosenshine, Simon Clare, Gordon Dougan, Gad Frankel.   

Abstract

Citrobacter rodentium is a member of a group of pathogens that colonize the lumen of the host gastrointestinal tract via attaching and effacing (A/E) lesion formation. C. rodentium, which causes transmissible colonic hyperplasia in mice, is used as an in vivo model system for the clinically significant A/E pathogens enterohemorrhagic and enteropathogenic Escherichia coli. These bacteria all contain a pathogenicity island called the locus of enterocyte effacement (LEE), which encodes a type III secretion system that is designed to deliver effector proteins into eukaryotic host cells. These effectors are involved in the subversion of host eukaryotic cell functions to the benefit of the bacterium. In this study we used mutant strains to determine the effects of the C. rodentium LEE-encoded effectors EspF, EspG, EspH, and Map on virulence in the mouse model. In addition, we identified a novel secreted protein, EspI encoded outside the LEE, whose secretion is also dependent on a functional type III secretion system. Mutant strains with each of the effectors investigated were found to be outcompeted by wild-type bacteria in mixed-infection experiments in vivo, although the effects of EspF and EspH were only subtle. In single-infection experiments, we found that EspF, EspG, and EspH are not required for efficient colonization of the mouse colon or for the production of hyperplasia. In contrast, strains producing EspI and Map had significant colonization defects and resulted in dramatically reduced levels of hyperplasia, and they exhibited very different growth dynamics in mice than the wild-type strain exhibited.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039354      PMCID: PMC375195          DOI: 10.1128/IAI.72.4.2288-2302.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Characterization of SepL of enterohemorrhagic Escherichia coli.

Authors:  A U Kresse; F Beltrametti; A Müller; F Ebel; C A Guzmán
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Complete nucleotide sequence of the prophage VT2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O157:H7 derived from the Sakai outbreak.

Authors:  K Makino; K Yokoyama; Y Kubota; C H Yutsudo; S Kimura; K Kurokawa; K Ishii; M Hattori; I Tatsuno; H Abe; T Iida; K Yamamoto; M Onishi; T Hayashi; T Yasunaga; T Honda; C Sasakawa; H Shinagawa
Journal:  Genes Genet Syst       Date:  1999-10       Impact factor: 1.517

4.  Targeting of an enteropathogenic Escherichia coli (EPEC) effector protein to host mitochondria.

Authors:  B Kenny; M Jepson
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

5.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

6.  Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice.

Authors:  J V Newman; B A Zabel; S S Jha; D B Schauer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Role of EspB in experimental human enteropathogenic Escherichia coli infection.

Authors:  C O Tacket; M B Sztein; G Losonsky; A Abe; B B Finlay; B P McNamara; G T Fantry; S P James; J P Nataro; M M Levine; M S Donnenberg
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Characterization of Escherichia coli DNA lesions generated within J774 macrophages.

Authors:  E Schlosser-Silverman; M Elgrably-Weiss; I Rosenshine; R Kohen; S Altuvia
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

9.  Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine.

Authors:  A D Phillips; S Navabpour; S Hicks; G Dougan; T Wallis; G Frankel
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

10.  Development of a universal intimin antiserum and PCR primers.

Authors:  M Batchelor; S Knutton; A Caprioli; V Huter; M Zanial; G Dougan; G Frankel
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

View more
  75 in total

1.  Enterohemorrhagic Escherichia coli virulence regulation by two bacterial adrenergic kinases, QseC and QseE.

Authors:  Jacqueline Njoroge; Vanessa Sperandio
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

2.  Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter.

Authors:  Xavier Charpentier; Eric Oswald
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

3.  Transcriptome of enterohemorrhagic Escherichia coli O157 adhering to eukaryotic plasma membranes.

Authors:  Sivan Dahan; Stuart Knutton; Robert K Shaw; Valerie F Crepin; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Genetic background and mobility of variants of the gene nleA in attaching and effacing Escherichia coli.

Authors:  Kristina Creuzburg; Sabine Heeren; Claudia M Lis; Markus Kranz; Michael Hensel; Herbert Schmidt
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

5.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 6.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 7.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

8.  Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion.

Authors:  Valérie F Crepin; Robert Shaw; Cecilia M Abe; Stuart Knutton; Gad Frankel
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

9.  Modulation of host microtubule dynamics by pathogenic bacteria.

Authors:  Girish K Radhakrishnan; Gary A Splitter
Journal:  Biomol Concepts       Date:  2012-12-01

Review 10.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.